Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
​US Life Science Patents to New Zealand assignees, 2015
By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909
The US Patent Office issues new patents every Tuesday. New Zealand assignees generally get one or two healthcare and biotech-related patents a month. Here are the 12 US patents relevant to New Zealand's Life Sciences sector that issued between 6 January 2015 and 29 December 2015. For patents issued in the last twelve months click here.
US Patent 9,212,204
Title: Treatment of Rett Syndrome using glycyl-L-2-methylprolyl-L-glutamic acid 
Issued: 15 December 2015
Assignee: Neuren Pharmaceuticals (ASX: NEU)
Description:  This patent covers Neuren's lead NNZ-2566 molecule for the treatment of the autism spectrum disorder Rett Syndrome.
US Patent 9,198,430
Title: Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
Issued: 1 December 2015
Assignee: Bayer New Zealand
Description:  This patent covers the combination of a macrocyclic lactone such as Doramectin, plus levamisole, for the treatment of parasitic infestations.
US Patent 9,119,851
Title: Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals
​Issued: 1 September 2015
Assignee: Neuren Pharmaceuticals (ASX: NEU)
Description: This patent covers Neuren's NNZ-2591 product for the treatment of cognitive impairment.
US Patent 9,102,743
Title: Immunogenic polypeptide isolated from Mycobacterium avium subspecies paratuberculosis and uses thereof
​Issued: 11 August 2015
Assignee: Massey University (50%), Institut Pasteur (France, 50%)
Description: This patent covers a vaccine for Johne's disease.​
US Patent 9,101,632
Title: Kinase inhibitors, prodrug forms thereof and their use in therapy
​Issued: 11 August 2015
Assignee: Auckland UniServices (University of Auckland)
Description: This patent covers hypoxia-activated prodrugs that give increased tumour-selectivity to novel kinase inhibitors.
US Patent 9,095,430
Title: Biomaterials with enhanced properties and devices made therefrom
​Issued: 4 August 2015
Assignee: Southern Lights Ventures​
Description: This patent covers glutaraldehyde-fixed neonatal pericardial tissue used to percutaneous heart valve leaflets.
US Patent 9,079,859
Title: Synthetic lethal targeting of glucose transport 
​Issued: 14 July 2015
Assignee:  Auckland UniServices (University of Auckland) (33%), Stanford University (US, 33%), Ruga Corp (US, 33%)
Description: This patent covers GLUT1 inhibitors to treat cancer via the HIF pathway.
US Patent 9,073,916
Title: Prodrug forms of kinase inhibitors and their use in therapy
​Issued: 7 July 2015
Assignee: Auckland UniServices (University of Auckland)
Description: This patent covers hypoxia-activated prodrugs that give increased tumour-selectivity to novel kinase inhibitors.
US Patent 9,045,505
Title: Nitric oxide donors
​Issued: 2 June 2015
Assignee: University of Otago (50%), Medical Research Council (UK, 50%)
Description: This patent covers nitrix oxide donors targeted to the mitochondria.
US Patent 9,040,485
Title: Synthetic analogues of neural regeneration peptides
​Issued: 26 May 2015
Assignee: CuroNZ
Description: This patent covers part of CuroNZ's library of neural regeneration peptides.
US Patent 8,993,019
Title: Emulsion
​Issued: 31 March 2015
Assignee: Massey University
Description: This patent the encapsulation of an oxidizable lipid, allowing it to be used for long-term shelf life of food.
US Patent 8,987,244
Title: Preventing and/or treating cardiovascular disease and/or associated heart failure
​Issued: 24 March 2015
Assignee: PhilERA (Professor Garth Cooper)
Description: This patent covers the use of new formulations of copper chelation drugs to treat various chronic diseases.

Copyright © 2016 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog